The Nature Index 2026 Research Leaders reveal the leading institutions and countries/territories in the natural sciences, health sciences, applied sciences and social sciences, according to their ...
This is my first time providing coverage of Faeth Therapeutics (FTH)—formerly known as Sensei Biotherapeutics—according to its Q1 2026 quarterly report/10Q filing: We are a clinical-stage ...
Relay Therapeutics is upgraded to Outperform with a $14 price target, driven by optimism for zovegalisib in PIK3CA-mutant HR+/HER2- metastatic breast cancer. Zovegalisib’s mutant-selective PI3Kα ...
Investors await clinical milestones for itraconazole in Gorlin Syndrome and potential new cancer indications. Updates expected post-quarter. Investors in Inhibitor Therapeutics are currently focused ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results